{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"False negative results in NAAT testing due to targeting a single gene\",\"Impact\":\"Undiagnosed infection leading to the potential spread of the virus\",\"Mitigation\":\"Use of a different specimen and target sequence in subsequent tests as recommended by WHO\",\"Technologies\":\"Nucleic Acid Amplification Tests (NAATs)\",\"People\":\"Patients undergoing NAAT testing\",\"Owner\":\"Healthcare professionals\"},{\"Description\":\"Inability of serological tests to detect early-stage infection\",\"Impact\":\"Delayed diagnosis and potential spread of the virus during the early stages of infection\",\"Mitigation\":\"Combining serological tests with other diagnostic methods for early detection\",\"Technologies\":\"Serological tests\",\"People\":\"Individuals being tested for COVID-19\",\"Owner\":\"Healthcare professionals\"},{\"Description\":\"Ambiguity in diagnosing past infections with NAAT and serological tests\",\"Impact\":\"Lack of insight into past infections and potential underestimation of the true infection rate\",\"Mitigation\":\"Use of complementary testing methods and thorough patient history to determine previous infection status\",\"Technologies\":\"Nucleic Acid Amplification Tests (NAATs), Serological tests\",\"People\":\"Healthcare professionals, individuals seeking testing\",\"Owner\":\"Public health authorities\"}]}"}}